Patents by Inventor Jean-Philippe GODIN

Jean-Philippe GODIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SCYLLO-INOSITOL AND ITS USE AS INSULIN SENSITIZER
    Publication number: 20220370378
    Abstract: The present invention relates generally to the field of insulin sensitizers. In particular, the present invention relates to scyllo-inositol for use as an insulin sensitizer in the treatment or prevention of hyperglycemia. The present invention further relates to scyllo-inositol for use as an insulin sensitizer in the treatment or prevention of disorders, conditions, and/or symptoms associated with hyperglycemia in a subject.
    Type: Application
    Filed: September 24, 2020
    Publication date: November 24, 2022
    Inventors: JOSE MANUEL RAMOS NIEVES, JEAN-PHILIPPE GODIN, IRMA SILVA ZOLEZZI, CHIARA NEMBRINI, KEITH MALCOLM GODFREY, SHIAO-YNG CHAN, WAYNE CUTFIELD
  • SCYLLO-INOSITOL AND B-CELL MEDIATED DISORDERS
    Publication number: 20220296534
    Abstract: The present invention relates generally to the field of ?-cell mediated disorders. In particular, the present invention relates to scyllo-inositol for use in the treatment or prevention of disorders linked to an impaired function of insulin secreting ?-cells. The present invention further relates to scyllo-inositol for use in the treatment or prevention of a condition or symptom associated with such disorders in a subject.
    Type: Application
    Filed: August 28, 2020
    Publication date: September 22, 2022
    Inventors: JEAN-PHILIPPE GODIN, IRMA SILVA ZOLEZZI, JOSE MANUEL RAMOS NIEVES, MARINE KRAUS
  • COMPOSITION COMPRISING ISOMERS OF INOSITOL AND ITS USE
    Publication number: 20210236528
    Abstract: A combination of scyllo-inositol and myo-inositol, wherein, the scyllo-inositol and myo-inositol are nutritional ingredients for use in the prevention or treatment of a condition selected from the group consisting of prediabetes, type II diabetes, gestational diabetes mellitus and a condition associated with any of the forgoing in a subject, and a composition comprising scyllo-inositol and myo-inositol.
    Type: Application
    Filed: August 22, 2019
    Publication date: August 5, 2021
    Inventors: Irma Silva Zolezzi, Jean-Philippe Godin, Shiao-Yng Chan, Keith Malcolm Godfrey
  • Method for determining fat free body mass
    Patent number: 10935543
    Abstract: The present invention relates to a method for determining a level of fat-free body mass (FFM) in a paediatric subject comprising determining a level of phenylacetylglutamine (PAG) in a sample obtained from the subject.
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: March 2, 2021
    Assignee: Societe des Produits Nestle S.A.
    Inventors: François-Pierre Martin, Omella Cominetti, Jean-Philippe Godin, Jessica Ezri, Andreas Nydegger
  • METHOD FOR DETERMINING FAT FREE BODY MASS
    Publication number: 20180356401
    Abstract: The present invention relates to a method for determining a level of fat-free body mass (FFM) in a paediatric subject comprising determining a level of phenylacetylglutamine (PAG) in a sample obtained from the subject.
    Type: Application
    Filed: December 30, 2016
    Publication date: December 13, 2018
    Inventors: Francois-Pierre Martin, Omella COMINETTI, Jean-Philippe GODIN, Jessica EZRI, Andreas NYDEGGER